{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:24:45Z","timestamp":1761596685526,"version":"build-2065373602"},"reference-count":115,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":7524,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1016\/s0301-472x(01)00730-5","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T08:16:31Z","timestamp":1027584991000},"page":"1247-1255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Dendritic cells in cancer vaccines"],"prefix":"10.1016","volume":"29","author":[{"given":"Peter","family":"Brossart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Wirths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram","family":"Brugger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Kanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0301-472X(01)00730-5_BIB1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.183.1.317","article-title":"Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo","volume":"183","author":"Paglia","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB3","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.4049\/jimmunol.158.7.3270","article-title":"Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL","volume":"158","author":"Brossart","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB4","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V90.4.1594","article-title":"Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells","volume":"90","author":"Brossart","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0952-7915(97)80153-7","article-title":"Origin, maturation and antigen presenting function of dendritic cells","volume":"9","author":"Cella","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.182.1.255","article-title":"Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes","volume":"182","author":"Porgador","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1084\/jem.183.1.87","article-title":"Therapy of murine tumors with tumor peptide-pulsed dendritic cells","volume":"183","author":"Zitvogel","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1074-7613(00)80370-2","article-title":"Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage","volume":"7","author":"Wu","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1074-7613(00)80649-4","article-title":"RelB is essential for the development of myeloid-related CD8\u03b1\u2212 dendritic cells but not of lymphoid-related CD8\u03b1+ dendritic cells","volume":"9","author":"Wu","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB12","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1084\/jem.183.4.1789","article-title":"A subclass of dendritic cells kills CD4 T cells via Fas\/Fas-ligand-induced apoptosis","volume":"183","author":"Suss","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1084\/jem.189.3.587","article-title":"CD8\u03b1+ and CD8\u03b1\u2212 subclasses of dendritic cells direct the development of distinct T helper cells in vivo","volume":"189","author":"Maldonado-Lopez","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB14","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.4049\/jimmunol.166.9.5327","article-title":"Cutting edge","volume":"166","author":"Pooley","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB15","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.192.12.1685","article-title":"CD8(+) but not CD8(\u2212) dendritic cells cross-prime cytotoxic T cells in vivo","volume":"192","author":"den Haan","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB16","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1126\/science.290.5499.2152","article-title":"Development of CD8\u03b1-positive dendritic cells from a common myeloid progenitor","volume":"290","author":"Traver","year":"2000","journal-title":"Science"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/82763","article-title":"IL-6 switches the differentiation of monocytes from dendritic cells to macrophages","volume":"1","author":"Chomarat","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1034\/j.1600-065X.2000.917305.x","article-title":"Mast cells in innate immunity","volume":"173","author":"Mekori","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB19","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1182\/blood.V92.11.4238","article-title":"Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor","volume":"92","author":"Brossart","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB20","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4049\/jimmunol.160.4.1666","article-title":"The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation","volume":"160","author":"Saint-Vis","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB21","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V90.4.1458","article-title":"CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor \u03b1","volume":"90","author":"Caux","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.165.1.566","article-title":"Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo","volume":"165","author":"Pulendran","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB23","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood.V95.8.2484","article-title":"Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells","volume":"95","author":"Arpinati","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/360258a0","article-title":"GM-CSF and TNF-\u03b1 cooperate in the generation of dendritic Langerhans cells","volume":"360","author":"Caux","year":"1992","journal-title":"Nature"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor \u03b1","volume":"179","author":"Sallusto","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB26","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1073\/pnas.93.6.2588","article-title":"CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells","volume":"93","author":"Zhou","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/eji.1830270213","article-title":"Differentiation of human dendritic cells from monocytes in vitro","volume":"27","author":"Chapuis","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0022-1759(96)00078-6","article-title":"Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability","volume":"196","author":"Romani","year":"1996","journal-title":"J Immunol Methods"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-065X.1996.tb00921.x","article-title":"The role of CD40 ligand in costimulation and T-cell activation","volume":"153","author":"Grewal","year":"1996","journal-title":"Immunol Rev"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0952-7915(97)80078-7","article-title":"Functions of CD40 on B cells, dendritic cells and other cells","volume":"9","author":"van Kooten","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB31","first-page":"4446","article-title":"Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis","volume":"60","author":"Jenne","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.188.7.1359","article-title":"Immature dendritic cells phagocytose apoptotic cells via \u03b1v\u03b25 and CD36, and cross-present antigens to cytotoxic T lymphocytes","volume":"188","author":"Albert","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB33","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.4049\/jimmunol.162.7.3757","article-title":"Cutting edge","volume":"162","author":"Arnold-Schild","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB35","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.4049\/jimmunol.154.10.5071","article-title":"Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells","volume":"154","author":"Macatonia","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","article-title":"Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity","volume":"184","author":"Cella","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB37","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.4049\/jimmunol.162.6.3202","article-title":"Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12","volume":"162","author":"Okamoto","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB38","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4049\/jimmunol.158.4.1541","article-title":"IFN-\u03b3-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12","volume":"158","author":"Kohno","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB39","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q","article-title":"Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC)","volume":"28","author":"Stoll","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB40","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/intimm\/10.11.1593","article-title":"High-level IL-12 production by human dendritic cells requires two signals","volume":"10","author":"Snijders","year":"1998","journal-title":"Int Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB41","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3","article-title":"Distinct patterns and kinetics of chemokine production regulate dendritic cell function","volume":"29","author":"Sallusto","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/42716","article-title":"A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells","volume":"387","author":"Adema","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4049\/jimmunol.160.2.555","article-title":"Detection of MCP-4 in dermal fibroblasts and its activation of the respiratory burst in human eosinophils","volume":"160","author":"Petering","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/intimm\/11.6.979","article-title":"Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site","volume":"11","author":"Foti","year":"1999","journal-title":"Int Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.4049\/jimmunol.161.3.1083","article-title":"Differential regulation of chemokine receptors during dendritic cell maturation","volume":"161","author":"Sozzani","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1084\/jem.188.2.373","article-title":"Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites","volume":"188","author":"Dieu","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0167-5699(98)01346-2","article-title":"Chemokines and chemokine receptors in T-cell priming and Th1\/Th2-mediated responses","volume":"19","author":"Sallusto","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB48","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.4049\/jimmunol.161.6.3096","article-title":"EBI1\/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation","volume":"161","author":"Yanagihara","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.188.1.181","article-title":"Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells","volume":"188","author":"Ngo","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB50","first-page":"4485","article-title":"Tumor necrosis factor \u03b1 and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells","volume":"60","author":"Brossart","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB51","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.151.5.2390","article-title":"Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance","volume":"151","author":"Enk","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4757-9966-8_53","article-title":"IL-10 prevents the generation of dendritic cells from CD14+ blood monocytes, promotes the differentiation to mature macrophages and stimulates endocytosis of FITC-dextran","volume":"417","author":"Allavena","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB53","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/eji.1830270326","article-title":"Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte\/macrophage-colony-stimulating factor","volume":"27","author":"Buelens","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB54","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.159.10.4772","article-title":"Induction of tolerance by IL-10-treated dendritic cells","volume":"159","author":"Steinbrink","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO;2-4","article-title":"IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages","volume":"28","author":"Allavena","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB56","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.184.2.741","article-title":"High level IL-12 production by murine dendritic cells","volume":"184","author":"Koch","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB57","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4049\/jimmunol.159.2.770","article-title":"Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells","volume":"159","author":"Qin","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB58","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1182\/blood.V93.5.1634","article-title":"Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells","volume":"93","author":"Steinbrink","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB59","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0952-7915(92)90082-P","article-title":"Interleukin-10","volume":"4","author":"de Waal","year":"1992","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB60","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4049\/jimmunol.155.4.2240","article-title":"IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response","volume":"155","author":"Kim","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB61","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1073\/pnas.89.16.7708","article-title":"Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies","volume":"89","author":"Pisa","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB62","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1084\/jem.182.2.477","article-title":"Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors","volume":"182","author":"Suzuki","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB63","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells","volume":"146","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB64","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","article-title":"Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes","volume":"174","author":"de Waal","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB65","first-page":"5330","article-title":"Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro","volume":"55","author":"Bakker","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB66","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00002371-200001000-00020","article-title":"Dendritic cells loaded with MART-1 peptide or infected with adenoviral construct are functionally equivalent in the induction of tumor-specific cytotoxic T lymphocyte responses in patients with melanoma","volume":"23","author":"Philip","year":"2000","journal-title":"J Immunother"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB67","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/1521-4141(2000)30:8<2115::AID-IMMU2115>3.0.CO;2-J","article-title":"Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART-1","volume":"30","author":"Minev","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1096-9098(199806)68:2<79::AID-JSO3>3.0.CO;2-H","article-title":"Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice","volume":"68","author":"DeMatos","year":"1998","journal-title":"J Surg Oncol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB69","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB70","first-page":"732","article-title":"Her-2\/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes","volume":"58","author":"Brossart","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB71","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/978-1-4757-9966-8_94","article-title":"Generation of in vitro autologous human cytotoxic T-cell response to E7 and HER-2\/neu oncogene products using ex-vivo peptide loaded dendritic cells","volume":"417","author":"Navabi","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB72","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1182\/blood.V93.12.4309","article-title":"Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies","volume":"93","author":"Brossart","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB73","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/eji.1830240930","article-title":"Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601","volume":"24","author":"van der Bruggen","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB74","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/eji.1830240340","article-title":"Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes","volume":"24","author":"Wolfel","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB75","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.179.3.921","article-title":"Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes","volume":"179","author":"Gaugler","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB76","first-page":"1099","article-title":"Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood","volume":"55","author":"Bernhard","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB77","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1073\/pnas.96.4.1532","article-title":"Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters","volume":"96","author":"Stuhler","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB78","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nbt0498-364","article-title":"Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA","volume":"16","author":"Nair","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB79","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1084\/jem.186.7.1177","article-title":"Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors","volume":"186","author":"Ashley","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB80","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1084\/jem.184.2.465","article-title":"Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo","volume":"184","author":"Boczkowski","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB81","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1073\/pnas.95.16.9482","article-title":"Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo","volume":"95","author":"Fields","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB82","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/73193","article-title":"Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids","volume":"6","author":"Kugler","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB83","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0925-4439(99)00108-8","article-title":"Human tumour and dendritic cell hybrids generated by electrofusion","volume":"1500","author":"Scott-Taylor","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB84","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-5357-1_44","article-title":"Hybrid cell vaccination in cancer immunotherapy. Recruitment and activation of T cell help for induction of anti tumour cytotoxic T cells","volume":"451","author":"Stuhler","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB85","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1464-410X.1998.00794.x","article-title":"Autologous and allogenic hybrid cell vaccine in patients with metastatic renal cell carcinoma","volume":"82","author":"Kugler","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB86","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1098-2264(199711)20:3<215::AID-GCC1>3.0.CO;2-5","article-title":"Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response","volume":"20","author":"Eibl","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB87","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0198-8859(96)00285-6","article-title":"Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells","volume":"53","author":"Smit","year":"1997","journal-title":"Hum Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB88","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1182\/blood.V89.4.1133","article-title":"Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia","volume":"89","author":"Choudhury","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB89","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1182\/blood.V93.3.780","article-title":"Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses","volume":"93","author":"Choudhury","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB90","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/eji.1830271209","article-title":"Pro-inflammatory cyto-kines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions","volume":"27","author":"Jonuleit","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB91","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.4049\/jimmunol.159.8.3823","article-title":"Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells","volume":"159","author":"Czerniecki","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB92","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1182\/blood.V90.4.1425","article-title":"flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions","volume":"90","author":"Strobl","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB93","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.193.2.233","article-title":"Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells","volume":"193","author":"Dhodapkar","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB94","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.192.9.1213","article-title":"Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells","volume":"192","author":"Jonuleit","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB95","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/blood.V96.1.91","article-title":"Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors","volume":"96","author":"Kikuchi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB96","first-page":"6391","article-title":"Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells","volume":"60","author":"Kikuchi","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB97","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/80498","article-title":"Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells","volume":"6","author":"Kikuchi","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB98","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1084\/jem.185.12.2133","article-title":"In vivo detection of dendritic cell antigen presentation to CD4(+) T cells","volume":"185","author":"Ingulli","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB99","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.4049\/jimmunol.165.12.6762","article-title":"The development, maturation, and turnover rate of mouse spleen dendritic cell populations","volume":"165","author":"Kamath","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB100","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.4049\/jimmunol.158.10.4543","article-title":"In vivo migration of dendritic cells differentiated in vitro","volume":"158","author":"Barratt-Boyes","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB101","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.4049\/jimmunol.164.5.2487","article-title":"Maturation and trafficking of monocyte-derived dendritic cells in monkeys","volume":"164","author":"Barratt-Boyes","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB102","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.4049\/jimmunol.166.6.4254","article-title":"Dendritic cells injected via different routes induce immunity in cancer patients","volume":"166","author":"Fong","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB103","first-page":"1331","article-title":"A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen","volume":"5","author":"Morse","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB104","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.165.6.3492","article-title":"Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells","volume":"165","author":"Schuler-Thurner","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB105","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1084\/jem.190.11.1669","article-title":"Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma","volume":"190","author":"Thurner","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB106","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0215(20000501)86:3<385::AID-IJC13>3.0.CO;2-T","article-title":"Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells","volume":"86","author":"Mackensen","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB107","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<121::AID-IJC20>3.0.CO;2-X","article-title":"Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA","volume":"82","author":"Nair","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(19990101)38:1<73::AID-PROS9>3.0.CO;2-V","article-title":"Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides","volume":"38","author":"Murphy","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB109","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood.V96.9.3102","article-title":"Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells","volume":"96","author":"Brossart","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB110","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.V93.7.2411","article-title":"Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma\u2014a feasibility study","volume":"93","author":"Reichardt","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB111","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB112","first-page":"842","article-title":"Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration","volume":"61","author":"Yu","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB113","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/CDLI.7.2.145-154.2000","article-title":"Evaluation of the modified ELISPOT assay for \u03b3 interferon production in cancer patients receiving antitumor vaccines","volume":"7","author":"Asai","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB114","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes (published erratum appears in Science 1998;280:1821)","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"10.1016\/S0301-472X(01)00730-5_BIB115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.165.2.613","article-title":"Cutting edge","volume":"165","author":"Skinner","year":"2000","journal-title":"J Immunol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X01007305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X01007305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:13:46Z","timestamp":1759565626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X01007305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":115,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S0301472X01007305"],"URL":"https:\/\/doi.org\/10.1016\/s0301-472x(01)00730-5","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2001,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cells in cancer vaccines","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0301-472X(01)00730-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}